+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid for primary sclerosing cholangitis Results of a 2-year randomized controlled trial evaluating single versus multiple daily doses



Ursodeoxycholic acid for primary sclerosing cholangitis Results of a 2-year randomized controlled trial evaluating single versus multiple daily doses



Hepatology 26(4 Part 2): 401A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144822

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. Journal of Hepatology 29(3): 417-423, 1998

Single versus three times daily ursodeoxycholic acid for primary sclerosing cholangitis Results of a randomized controlled trial. Gastroenterology 110(4 Suppl. ): A1352, 1996

A randomized controlled trial evaluating therapy with ursodeoxycholic acid in daily doses of 10 mg/kg versus 20 mg/kg in primary biliary cirrhosis. Gastroenterology 114(4 Part 2): A1358, 1998

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. Hepatology 40(6): 1379-1386, 2004

Ursodeoxycholic acid therapy for primary sclerosing cholangitis Preliminary report of a randomized controlled trial. Hepatology 16(4 Part 2): 62A, 1992

Single dose or multiple doses of ursodeoxycholic acid are equally effective in the treatment of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 108(4 Suppl. ): A1191, 1995

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 129(5): 1464-1472, 2005

High dose ursodeoxycholic acid in primary sclerosing cholangitis Results after two years of a randomised double-blind placebo-controlled trial. Gut 40(Suppl. 1): A29, 1997

A randomized trial of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis. Gastroenterology 110(4 Suppl. ): A1252, 1996

Effect of ursodeoxycholic acid in primary sclerosing cholangitis a controlled trial. Hepatology 14(4 Part 2): 64A, 1991

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 16(3): 707-714, 1992

Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials. Hepatology Research 39(9): 865-873, 2009

Ursodeoxycholic acid in primary sclerosing cholangitis A double-blind placebo controlled trial. Hepatology 16(4 Part 2): 92A, 1992

Treatment of primary sclerosing cholangitis with ursodeoxycholic acid first results of a controlled study. Hepatology 10(4): 602, 1989

A randomized, cross-over study evaluating single- and multiple-daily dosage schedules of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 122(4 Suppl 1): A 629, 2002